Two Negative Studies of Mirtazapine and Riluzole for PTSD in Veterans
The Carlat Psychiatry Report, Volume 19, Number 6&7, June 2021
Richard Moldawsky, MD.
Dr. Moldawsky has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Medications don’t have a good track record in PTSD, particularly in combat related trauma. Here we review two controlled trials where an old standby (mirtazapine) and a hopeful contender (riluzole) come up short.